Results 161 to 170 of about 583,925 (313)

What's in it for me? A mixed-methods study on teachers' value creation in an inter-institutional community on open educational resources in higher education. [PDF]

Educ Inf Technol (Dordr), 2023
Baas M, Schuwer R, van den Berg E, Huizinga T, Huizinga T, van der Rijst R, Admiraal W.   +6 more
europepmc   +1 more source

Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution

Molecular Oncology, EarlyView.
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski, Liudmyla Dolinchuk, Michał Jerzak, Albert Gandurski, Tomasz Grochowski, Weronika Wojtyś, Maciej Zadrożny, Wojciech Kaźmierczak, Małgorzata Lenarcik, Marta Matejak‐Górska, Radosław Samsel, Tomasz Olesiński, Dawid Walerych   +12 more
wiley   +1 more source

Shareholders and stakeholders value creation: an analytic foundation for value creation indicators

PSL Quarterly Review, 2007
Article originally published in the volume 60 issue 240 of Banca Nazionale del Lavoro Quarterly Review (also known as BNL Quarterly Review).
Giancarlo Mazzoni, Rainer S. Masera
doaj  

Toward Economic Growth and Value Creation Through Social Entrepreneurship: Modelling the Mediating Role of Innovation. [PDF]

Front Psychol, 2022
Wang W.
europepmc   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

An integrative framework of value [PDF]

The concept of value has been discussed for over 2000 years with various nuanced meanings. It was a focus of concern for Plato and Aristotle, and Adam Smith (1776) dealt extensively with value in The Wealth of Nations.
Smith, Laura A., Ng, Irene C. L.
core  

Value in psoriasis (IRIS) trial: implementing value-based healthcare in psoriasis management - a 1-year prospective clinical study to evaluate feasibility and value creation. [PDF]

BMJ Open, 2023
Hilhorst N, Roman E, Borzée J, Deprez E, Hoorens I, Cardoen B, Roodhooft F, Lambert J.   +7 more
europepmc   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source

The value management cycle as a sustainable HRM framework: insights from Chinese Huawei's practices of value creation, evaluation, and distribution. [PDF]

Front Psychol
Liang R.
europepmc   +1 more source

Early evidence on how Industry 4.0 reshapes MNEs' global value chains: The role of value creation versus value capturing by headquarters and foreign subsidiaries. [PDF]

J Int Bus Stud, 2023
Lee JY, Kim D, Choi B, Jiménez A.
europepmc   +1 more source